Skip to main content

Table 3 Relationship between the period of time and SARS-CoV-2 infection among 343 blood donors from Luanda, Angola

From: Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola

Months

2019–2020

N (%)

Anti-SARS-CoV-2 positivity

Past infection

Recent infection

Univariate analysis

  

No (%)

Yes (%)

p-value*

No (%)

Yes (%)

p-value*

No (%)

Yes (%)

p-value*

OR (95% CI)

p-value

December/2019

25 (7.3)

25 (100)

0 (0.0)

 < 0.001

25 (100)

0 (0.0)

 < 0.001

25 (100)

0 (0.0)

0.452

0 (0.0–0.0)

0.998

January/2020

145 (42.3)

144 (99.3)

1 (0.7)

 

145 (100)

0 (0.0)

 

144 (99.3)

1 (0.7)

 

0.03 (0.0–0.22)

0.001

February/2020

42 (12.2)

42 (100)

0 (0.0)

 

42 (100)

0 (0.0)

 

42 (100)

0 (0.0)

 

0 (0.0–0.0)

0.997

July/2020

52 (15.2)

51 (98.1)

1 (1.9)

 

52 (100)

0 (0.0)

 

51 (98.1)

1 (1.9)

 

0.08 (0.01–0.63)

0.017

August/2020

24 (7.0)

21 (87.5)

3 (12.5)

 

22 (91.7)

2 (8.3)

 

23 (95.8)

1 (4.2)

 

0.57 (0.14–2.27)

0.426

September/2020

55 (16.0)

44 (80.0)

11 (20.0)

 

46 (83.6)

9 (16.4)

 

53 (96.4)

2 (3.6)

 

1.00

  1. Past infection (IgG+/IgM−) and Recent infection (IgG−/IgM+ or IgG+/IgM+)
  2. The bold numbers were statistically significant (p < 0.05)
  3. *Chi-square test (X2)